After several cycles of lab testing on test animals, a medication can enter clinical trials for evaluation in humans. In phase II clinical trial testing:
A) the trial is expanded to include a large sample size, usually in the thousands of individuals, and establish the overall safety and effectiveness of the drug.
B) the medication is compared to other medications on the market.
C) consists of the drug being tested on a small number (usually 300 or less) of people with the illness or condition the drug is designed to treat.
D) researchers attempt to determine the safe dose and how the medication is both absorbed and eliminated from the body.
Answer: C
You might also like to view...
In Maslow's hierarchy of needs, which level includes physical safety and security relating to employment?
a. Level I b. Level II c. Level III d. Level IV
Please complete the following sentence, "The overall medical decision making is selected by:
A. the lowest of the three elements, number of diagnosis(es) and/or management options, amount and/or complexity of data, risk of complications, comorbidity, or mortality. B. the highest of the three of the elements, number of diagnosis(es) and/or management options, amount and/or complexity of data, risk of complications, comorbidity, or mortality. C. two of the three elements of medical decision making - number of diagnosis(es) and/or management options, amount and/or complexity of data, risk of complications, comorbidity, or mortality - must be met or exceeded. D. the level of the risk of complications, comorbidity, or mortality determines the overall medical decision making.